v3.21.1
Consolidated Operations Statements - USD ($)
3 Months Ended 9 Months Ended
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2021
Jan. 31, 2020
Income Statement [Abstract]        
Revenues $ 2,145,988 $ 34,538 $ 3,122,077 $ 34,538
Cost of goods sold 1,576,265 16,234 2,351,153 16,234
Gross Margin 569,723 18,304 770,924 18,304
Operating Expenses        
Operations 146,539 353,295
Research and development 167,968 94,979 341,892 354,146
Sales and marketing 48,719 97,534
General and administrative expenses 499,155 212,482 929,874 478,871
Stock based compensation 854,195 149,462 1,068,317 161,529
Total operating expenses 1,716,576 456,923 2,790,912 994,546
Operating loss (1,146,853) (438,619) (2,019,988) (976,242)
Other expense        
Amortization Expense 5,571 5,571
Derivative Expense 4,481,701 4,630,288
Change in Fair Value of Derivative 3,350,135 3,433,938
Other expense 7,837,407 8,069,797
Net loss $ (8,984,260) $ (438,619) $ (10,089,785) $ (976,242)
Loss per share - basic and diluted $ (0.34) $ (0.02) $ (0.46) $ (0.08)
Weighted average shares outstanding - basic and diluted 26,232,755 17,732,298 22,161,745 11,556,950

Source